289 related articles for article (PubMed ID: 34763472)
1. Riociguat therapy for pulmonary hypertension: a systematic review and meta-analysis.
Wang L; Zhu L; Wu Y; Li Q; Liu H
Ann Palliat Med; 2021 Oct; 10(10):11117-11128. PubMed ID: 34763472
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of riociguat in the treatment of chronic thromboembolic pulmonary arterial hypertension: A meta-analysis.
Ying M; Song J; Gu S; Zhao R; Li M
Medicine (Baltimore); 2021 Jun; 100(22):e26211. PubMed ID: 34087896
[TBL] [Abstract][Full Text] [Related]
3. Long-term clinical value and outcome of riociguat in chronic thromboembolic pulmonary hypertension.
van Thor MCJ; Ten Klooster L; Snijder RJ; Post MC; Mager JJ
Int J Cardiol Heart Vasc; 2019 Mar; 22():163-168. PubMed ID: 30859124
[TBL] [Abstract][Full Text] [Related]
4. Change of right heart size and function by long-term therapy with riociguat in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.
Marra AM; Egenlauf B; Ehlken N; Fischer C; Eichstaedt C; Nagel C; Bossone E; Cittadini A; Halank M; Gall H; Olsson KM; Lange TJ; Grünig E
Int J Cardiol; 2015 Sep; 195():19-26. PubMed ID: 26011408
[TBL] [Abstract][Full Text] [Related]
5. Balloon pulmonary angioplasty vs riociguat in patients with inoperable chronic thromboembolic pulmonary hypertension: A systematic review and meta-analysis.
Wang W; Wen L; Song Z; Shi W; Wang K; Huang W
Clin Cardiol; 2019 Aug; 42(8):741-752. PubMed ID: 31188483
[TBL] [Abstract][Full Text] [Related]
6. Riociguat for the treatment of chronic thromboembolic pulmonary hypertension.
Ghofrani HA; D'Armini AM; Grimminger F; Hoeper MM; Jansa P; Kim NH; Mayer E; Simonneau G; Wilkins MR; Fritsch A; Neuser D; Weimann G; Wang C;
N Engl J Med; 2013 Jul; 369(4):319-29. PubMed ID: 23883377
[TBL] [Abstract][Full Text] [Related]
7. Overview of Riociguat and Its Role in the Treatment of Pulmonary Hypertension.
Kenny M; Clarke MM; Pogue KT
J Pharm Pract; 2022 Jun; 35(3):437-444. PubMed ID: 33084500
[TBL] [Abstract][Full Text] [Related]
8. Riociguat for patients with chronic thromboembolic pulmonary hypertension: Usefulness of transitioning from phosphodiesterase type 5 inhibitor.
Yamamoto K; Tanabe N; Suda R; Sasaki A; Matsumura A; Ema R; Kasai H; Kato F; Sekine A; Nishimura R; Jujo T; Sugiura T; Shigeta A; Sakao S; Tatsumi K
Respir Investig; 2017 Jul; 55(4):270-275. PubMed ID: 28705306
[TBL] [Abstract][Full Text] [Related]
9. Right ventricular size and function under riociguat in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension (the RIVER study).
Marra AM; Halank M; Benjamin N; Bossone E; Cittadini A; Eichstaedt CA; Egenlauf B; Harutyunova S; Fischer C; Gall H; Ghofrani HA; Hoeper MM; Lange TJ; Olsson KM; Klose H; Grünig E
Respir Res; 2018 Dec; 19(1):258. PubMed ID: 30567595
[TBL] [Abstract][Full Text] [Related]
10. Influence of riociguat treatment on pulmonary arterial hypertension : A meta-analysis of randomized controlled trials.
Zhao R; Jiang Y
Herz; 2019 Nov; 44(7):637-643. PubMed ID: 29992431
[TBL] [Abstract][Full Text] [Related]
11. Riociguat for pulmonary arterial hypertension associated with congenital heart disease.
Rosenkranz S; Ghofrani HA; Beghetti M; Ivy D; Frey R; Fritsch A; Weimann G; Saleh S; Apitz C
Heart; 2015 Nov; 101(22):1792-9. PubMed ID: 26135803
[TBL] [Abstract][Full Text] [Related]
12. Riociguat: Mode of Action and Clinical Development in Pulmonary Hypertension.
Ghofrani HA; Humbert M; Langleben D; Schermuly R; Stasch JP; Wilkins MR; Klinger JR
Chest; 2017 Feb; 151(2):468-480. PubMed ID: 27263466
[TBL] [Abstract][Full Text] [Related]
13. Guanylate cyclase stimulators for pulmonary hypertension.
Wardle AJ; Seager MJ; Wardle R; Tulloh RM; Gibbs JS
Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD011205. PubMed ID: 27482837
[TBL] [Abstract][Full Text] [Related]
14. Riociguat: a review of its use in patients with chronic thromboembolic pulmonary hypertension or pulmonary arterial hypertension.
Garnock-Jones KP
Drugs; 2014 Nov; 74(17):2065-78. PubMed ID: 25352393
[TBL] [Abstract][Full Text] [Related]
15. Riociguat for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.
Bishop BM
Am J Health Syst Pharm; 2014 Nov; 71(21):1839-44. PubMed ID: 25320133
[TBL] [Abstract][Full Text] [Related]
16. Riociguat in patients with chronic thromboembolic pulmonary hypertension: results from an early access study.
McLaughlin VV; Jansa P; Nielsen-Kudsk JE; Halank M; Simonneau G; Grünig E; Ulrich S; Rosenkranz S; Gómez Sánchez MA; Pulido T; Pepke-Zaba J; Barberá JA; Hoeper MM; Vachiéry JL; Lang I; Carvalho F; Meier C; Mueller K; Nikkho S; D'Armini AM
BMC Pulm Med; 2017 Dec; 17(1):216. PubMed ID: 29282032
[TBL] [Abstract][Full Text] [Related]
17. Haemodynamic effects of riociguat in inoperable/recurrent chronic thromboembolic pulmonary hypertension.
Kim NH; D'Armini AM; Grimminger F; Grünig E; Hoeper MM; Jansa P; Mayer E; Neurohr C; Simonneau G; Torbicki A; Wang C; Fritsch A; Davie N; Ghofrani HA
Heart; 2017 Apr; 103(8):599-606. PubMed ID: 28011757
[TBL] [Abstract][Full Text] [Related]
18. Beneficial effects of riociguat on hemodynamic responses to exercise in CTEPH patients after balloon pulmonary angioplasty - A randomized controlled study.
Aoki T; Sugimura K; Terui Y; Tatebe S; Fukui S; Miura M; Yamamoto S; Yaoita N; Suzuki H; Sato H; Kozu K; Konno R; Miyata S; Nochioka K; Satoh K; Shimokawa H
Int J Cardiol Heart Vasc; 2020 Aug; 29():100579. PubMed ID: 32685661
[TBL] [Abstract][Full Text] [Related]
19. Bosentan therapy for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: A systemic review and meta-analysis.
Chen X; Zhai Z; Huang K; Xie W; Wan J; Wang C
Clin Respir J; 2018 Jun; 12(6):2065-2074. PubMed ID: 29393580
[TBL] [Abstract][Full Text] [Related]
20. Riociguat for idiopathic interstitial pneumonia-associated pulmonary hypertension (RISE-IIP): a randomised, placebo-controlled phase 2b study.
Nathan SD; Behr J; Collard HR; Cottin V; Hoeper MM; Martinez FJ; Corte TJ; Keogh AM; Leuchte H; Mogulkoc N; Ulrich S; Wuyts WA; Yao Z; Boateng F; Wells AU
Lancet Respir Med; 2019 Sep; 7(9):780-790. PubMed ID: 31416769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
